Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Concomitant Mutation NSCLC
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Anlotinib
Related studies linked through entity extraction aliases.
Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- NA
Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib to Malignant Brainstem Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)
- Status
- UNKNOWN
- Phase
- PHASE3
Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Gefitinib With Anlotinib in Advanced Non-squamous NSCLC Patients With Uncleared Plasma ctDNA EGFRm After First-line Treatment With Gefitinib
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE3
Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2